Steve Jobs’s legacy in personalized medicine

Steve Jobs was one of the first people—and certainly the best-known—to try an all-in genetic strategy to beat cancer. As recounted in Walter Isaacson’s biography of the Apple CEO, Jobs spent $100,000 to learn the DNA sequence of his genome and that of the tumors killing him. Jobs was jumping between treatments and hoped DNA would provide clues about where to turn next.

One of Jobs’s doctors I spoke to indicated that in the end DNA did not prove key to steering his treatment. But Jobs believed that medicine was taking strides. He famously said, “I’m either going to be one of the first to be able to outrun a cancer like this, or I’m going to be one of the last to die from it.”

Related on the SLP

Why elephants almost never get cancer–and why that might save human lives Obsessive-compulsive disorder in dogs: What can we learn about ourselves?

Viewpoint: America Last: From the Pentagon to universities, Trump’s corruption of science could inflict lasting, irreversible damage on U.S. research

Helpful until we’re helpless? Researchers warn AI is gradually eroding human control

‘Silent killer’: Hepatitis B could surge under Trump–RFK Jr. rollback of newborn vaccine recommendations

Read the full, original story here: Steve Jobs Left a Legacy on Personalized Medicine

• “With Death, Christopher Hitchens And Steve Jobs Showed Us The Limits Of DNA Sequencing,” Forbes
• “Steve Jobs’ Cancer Journey: Why decoding his genome didn’t save him,” TIME
• “In Treatment for Leukemia, Glimpses of the Future,” New York Times